Literature DB >> 20406216

Novel targets and regulatory ordeal by QT interval.

J M Ritter.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20406216      PMCID： PMC2848405          DOI： 10.1111/j.1365-2125.2010.03657.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  17 in total

1.  Icatibant.

Authors:  Eline A Dubois; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

Review 2.  Clinical pharmacology--providing tools and expertise for translational medicine.

Authors:  J K Aronson; A Cohen; L D Lewis
Journal:  Br J Clin Pharmacol       Date:  2008-02       Impact factor: 4.335

3.  Drug-induced long QT syndrome and drug development.

Authors:  J M Ritter
Journal:  Br J Clin Pharmacol       Date:  2008-09       Impact factor: 4.335

4.  Eculizumab.

Authors:  Eline A Dubois; Adam F Cohen
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

5.  [Ventricular tachycardia with 2 variable opposing foci].

Authors:  F Dessertenne
Journal:  Arch Mal Coeur Vaiss       Date:  1966-02

6.  Severity of pancreatitis-associated gut barrier dysfunction is reduced following treatment with the PAF inhibitor lexipafant.

Authors:  Per Leveau; Xiangdong Wang; Zhengwu Sun; Anna Börjesson; Ellen Andersson; Roland Andersson
Journal:  Biochem Pharmacol       Date:  2005-05-01       Impact factor: 5.858

Review 7.  Rupatadine: a review of its use in the management of allergic disorders.

Authors:  Susan J Keam; Greg L Plosker
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Cisapride and ventricular arrhythmia.

Authors:  Sean Hennessy; Charles E Leonard; Craig Newcomb; Stephen E Kimmel; Warren B Bilker
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

9.  Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

Authors:  Ruth Dixon; Sarah Job; Ruth Oliver; Debra Tompson; John G Wright; Kay Maltby; Ulrike Lorch; Jorg Taubel
Journal:  Br J Clin Pharmacol       Date:  2008-07-23       Impact factor: 4.335

Review 10.  Annexin A1 and glucocorticoids as effectors of the resolution of inflammation.

Authors:  Mauro Perretti; Fulvio D'Acquisto
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.